STRUCTURE AND MECHANISM OF THE E COLI MANNITOL PERMEASE
大肠杆菌甘露醇渗透酶的结构和机制
基本信息
- 批准号:2175139
- 负责人:
- 金额:$ 21.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-07-01 至 1998-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our laboratory is investigating the structure and mechanism of the
enzyme/permease responsible for the coupled transport and phosphorylation
of the hexitol D-mannitol in Escherichia coli. This protein is an
integral membrane component of the bacterial phosphotransferase system
(PTS) and also serves as a chemotactic receptor for D-mannitol in E,
coli. Over the past decade, its structure and catalytic mechanism have
been extensively studied by biochemical, biophysical and genetic
techniques. The mannitol permease remains the most attractive transport
protein of the PTS to study because it has been purified, its gene has
been cloned and sequenced, and its overall disposition with respect to
the membrane is known. The broad objective of these studies is to
determine in as much molecular detail as possible the mechanism by which
the mannitol permease carries out its receptor and transport functions.
This is not completely known for any membrane transport protein, and the
results of these studies should therefore add fundamental knowledge to
the understanding of transport protein structure and function. Since all
cells rely on proper functioning of transport proteins for interaction
with their environment, and some diseased cells may lack one or more of
these functions, the study of these fundamental processes is essential
in understanding the basic principles underlying growth and metabolism
in both normal and diseased cells. Moreover, since many pathogenic
bacteria have a PTS, but this system is absent in eucaryotes, it is a
potential target for antibacterial agents. In the proposed project
continuation, the aims are to: 1) continue to isolate and characterize
mutants in the mannitol permease; 2) use complementation studies and the
isolation of pseudorevertants to characterize important interactions in
the permease; 3) study the structure of the permease including attempts
to crystallize it; and 4) study a structurally related protein, ORF162,
which may be a regulatory link between the PTS and nitrogen assimilation
in bacteria. A combination of biochemical, biophysical, molecular
biological and genetic techniques will be used to accomplish these aims.
Collaborations and consultations with other workers in this area will
ensure a complementary, rather than a competitive expenditure of time and
effort in this project. Successful completion of this work will lead to
significant progress toward our overall goal of understanding the
molecular basis of transport and chemoreception in this system.
我们的实验室正在研究的结构和机制,
负责偶联转运和磷酸化的酶/通透酶
己糖醇D-甘露醇在大肠杆菌。 这种蛋白质是
细菌磷酸转移酶系统的整体膜组件
(PTS)并且还作为E中D-甘露醇的趋化性受体,
杆菌 在过去的十年里,它的结构和催化机制,
生物化学、生物物理学和遗传学已经广泛地研究了
技术. 甘露醇通透酶仍然是最有吸引力的转运蛋白
PTS的蛋白质进行研究,因为它已经被纯化,其基因具有
克隆和测序,以及其在
膜是已知的。 这些研究的主要目标是
尽可能多地确定分子细节,
甘露醇通透酶执行其受体和转运功能。
这对于任何膜转运蛋白都不是完全已知的,
因此,这些研究的结果应该增加基础知识,
对转运蛋白结构和功能的理解。 由于所有
细胞依赖于转运蛋白的正常功能进行相互作用
与其环境,和一些病变细胞可能缺乏一个或多个
这些功能,这些基本过程的研究是必要的
了解生长和新陈代谢的基本原理
在正常细胞和病变细胞中。 此外,由于许多病原体
细菌有一个PTS,但这个系统在真核生物中是不存在的,它是一个
抗菌剂的潜在靶点。 拟建工程
继续,目标是:1)继续分离和表征
甘露醇渗透酶的突变体; 2)使用互补研究,
分离假回复突变体以表征
3)研究了通透酶的结构,包括尝试
使其结晶;以及4)研究结构相关的蛋白质,ORF 162,
这可能是PTS和氮同化之间的调节联系
在细菌中。 结合生物化学,生物物理,分子
将利用生物和遗传技术来实现这些目标。
与该领域其他工作者的合作和协商将
确保时间的消耗是互补的,而不是竞争性的,
在这个项目上的努力。 这项工作的顺利完成将导致
我们的总体目标是了解
在这个系统中的运输和化学感受的分子基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY R JACOBSON其他文献
GARY R JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY R JACOBSON', 18)}}的其他基金
CROSS-DISCIPLINARY UNDERGRADUATE BIOMEDICAL RESEARCH
跨学科本科生物医学研究
- 批准号:
6711772 - 财政年份:2001
- 资助金额:
$ 21.34万 - 项目类别:
CROSS-DISCIPLINARY UNDERGRADUATE BIOMEDICAL RESEARCH
跨学科本科生物医学研究
- 批准号:
6232475 - 财政年份:2001
- 资助金额:
$ 21.34万 - 项目类别:
CROSS-DISCIPLINARY UNDERGRADUATE BIOMEDICAL RESEARCH
跨学科本科生物医学研究
- 批准号:
6636565 - 财政年份:2001
- 资助金额:
$ 21.34万 - 项目类别:
CROSS-DISCIPLINARY UNDERGRADUATE BIOMEDICAL RESEARCH
跨学科本科生物医学研究
- 批准号:
6520394 - 财政年份:2001
- 资助金额:
$ 21.34万 - 项目类别:
MECHANISMS OF SUGAR TRANSPORT IN STREPTOCOCCUS MUTANS
变形链球菌的糖转运机制
- 批准号:
3219677 - 财政年份:1982
- 资助金额:
$ 21.34万 - 项目类别:
MECHANISMS OF SUGAR TRANSPORT IN STREPTOCOCCUS MUTANS
变形链球菌的糖转运机制
- 批准号:
3219675 - 财政年份:1982
- 资助金额:
$ 21.34万 - 项目类别:
MECHANISMS OF SUGAR TRANSPORT IN STREPTOCOCCUS MUTANS
变形链球菌的糖转运机制
- 批准号:
3219678 - 财政年份:1982
- 资助金额:
$ 21.34万 - 项目类别:
STRUCTURE AND MECHANISM OF THE E COLI MANNITOL PERMEASE
大肠杆菌甘露醇渗透酶的结构和机制
- 批准号:
3275531 - 财政年份:1980
- 资助金额:
$ 21.34万 - 项目类别:
STRUCTURE AND MECHANISM OF E COLI D-MANNITOL PERMEASE
大肠杆菌D-甘露醇渗透酶的结构与机制
- 批准号:
3275530 - 财政年份:1980
- 资助金额:
$ 21.34万 - 项目类别:
STRUCTURE AND MECHANISM OF THE E COLI MANNITOL PERMEASE
大肠杆菌甘露醇渗透酶的结构和机制
- 批准号:
2175140 - 财政年份:1980
- 资助金额:
$ 21.34万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 21.34万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 21.34万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 21.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)